Ahmed A. Awan, MD, on the Management of HCV in Chronic Kidney Disease
In this podcast, Ahmed A. Awan, from Baylor College of Medicine, discusses the management of hepatitis C virus (HCV) infection among patients with chronic kidney disease (CKD) according to the most recent clinical practice guideline from Kidney Disease: Improving Global Outcomes (KDIGO), how direct-acting agents for the management of HCV infection affect the management of CKD, the role of interferon-free regimens, and more.
Ahmed A. Awan, MD, is an assistant professor in the Division of Abdominal Transplantation at Baylor College of Medicine in Houston, Texas.
Reference:
Awan AA, Jadoul M, Martin P. Hepatitis C in chronic kidney disease: an overview of the KDIGO guideline [published online July 31, 2019]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2019.07.050.